Structured evidence table for Phosphatidylserine Cognition Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Phosphatidylserine Cognition Randomized Trial | This study aimed to evaluate the effects of PS on core symptoms and associated behavioral problems in children with ADHD. | 4 | Shen Z (2026) | The effect of phosphatidylserine on behavioral problems in children with attention deficit hyperactivity disorder. |
| Phosphatidylserine Cognition Randomized Trial | In contrast, the PS group demonstrated significant reductions in internalizing (M = 1.83, SD = 3.28, p < 0.05, d = 0.56) and externalizing behaviors (M = 3.38, SD = 5.20, p < 0.05, d = 0.65), whereas the atomoxetine group improved only in externalizing behaviors (M = 2.54, SD = 5.42, p < 0.05, d = 0.47). | 4 | Shen Z (2026) | The effect of phosphatidylserine on behavioral problems in children with attention deficit hyperactivity disorder. |
| Phosphatidylserine Cognition Randomized Trial | Phosphatidylserine was not associated with significant improvements in core ADHD symptoms but was associated with reductions in internalizing and externalizing behavioral problems, particularly in reducing aggression. | 4 | Shen Z (2026) | The effect of phosphatidylserine on behavioral problems in children with attention deficit hyperactivity disorder. |
| Phosphatidylserine Cognition Randomized Trial | Attention Deficit Hyperactivity Disorder (ADHD) is a common neurodevelopmental disorder in children, characterized by attention deficit, hyperactivity, and various internalizing and externalizing behavioral problems. | 4 | Shen Z (2026) | The effect of phosphatidylserine on behavioral problems in children with attention deficit hyperactivity disorder. |
| Phosphatidylserine Cognition Randomized Trial | Phosphatidylserine Supplementation on Psychomotor Speed among Healthy Adults with Subjective Cognitive Declines | 4 | Phosphatidylserine Supplementation on Psychomotor Speed among Healthy Adults with Subjective Cognitive Declines (2025) | Phosphatidylserine Supplementation on Psychomotor Speed among Healthy Adults with Subjective Cognitive Declines |
Source documents